 | | | | Brazilian food processor BRF SA on Wednesday recalled almost 500 tonnes of fresh chicken products produced at its Dourados plant citing possible salmonella contamination, a securities filing showed. | | | | | | British pharmaceutical firm Clinigen Group Plc said on Wednesday it acquired the U.S. rights to Swiss drugmaker Novartis AG's skin and lung cancer drug Proleukin for a total of $210 million, including some future payments. | | | | | | An advisory panel to the U.S. Food and Drug Administration on Tuesday voted in favor of Johnson & Johnson's experimental nasal spray, which has a compound similar to often-abused ketamine, bringing the drug closer to approval. | | | | | | (Reuters Health) - People who eat a lot of animal protein may be more likely to have excessive fat in their livers and a higher risk of liver disease than individuals whose main source of protein is vegetables, a Dutch study suggests. | | | | | | (Reuters Health) - It looks like your mother was right: when you've got a cold, sleep may be the best medicine. | | | | | | (Reuters Health) - Even relatively healthy heart failure patients may still be more likely to die after surgery than people with healthier hearts, a U.S. study suggests. | | | | | | (Reuters Health) - Over the last three decades, improved screening and treatments may have kept hundreds of thousands of women from dying of breast cancer, computer simulations suggest. | | | | | | Mylan NV on Tuesday priced its generic version of GlaxoSmithKline's blockbuster asthma treatment Advair 70 percent lower than the branded medicine. | | | | | | A generation of music-lovers are damaging their hearing with audio players that do not limit dangerously high noise levels, the U.N. health agency said on Tuesday. | | | | | | Generic competitors to British drugmaker Indivior Plc's blockbuster opioid addiction treatment are on course to launch sales next week after the firm's attempt to stay a U.S. District court judgement was rejected. | | | | | | Drugmaker Merck & Co Inc said on Monday that the combination of its cancer immunotherapy Keytruda with Pfizer Inc's Inlyta cut the risk of death nearly in half for patients with the most common form of kidney cancer when compared with treatment with chemotherapy drug Sutent. | | | | | |
